Jazz Pharma PLC Live Stock Price Today, Share Analysis and Chart

Name: Jazz Pharmaceuticals plc: Is Infosys Ltd. worth buying?
Item: Jazz Pharmaceuticals plc
Rating: 1.545069375
Author: Trendlyne DVM scores

Momentum Trap

about

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

195.93 4.99 (2.61%)

Near 52W High of $198.00

1.0M

XNAS Volume

XNAS 08 Apr, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Jazz Pharma PLC is on 15 Apr 2026 for the purpose of Needham Virtual Healthcare Conference See details

Low Financial Strength

11.1 / 100

Mid Valuation

32.3 / 100

Technically Moderately Bullish

69.1 / 100

Momentum Trap These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks View Similar Embed DVM

224

1Yr Price target upside is 14%

16 analysts

Jazz Pharma PLC Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Jazz Pharma PLC Live Stock Price Today, Share Analysis and Chart

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

Near 52W High of $198.00

SWOT Analysis

Jazz Pharma PLC Live Price Chart